{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:03:36Z","timestamp":1777701816223,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["18H02336"],"award-info":[{"award-number":["18H02336"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["18KK0188"],"award-info":[{"award-number":["18KK0188"]}]},{"name":"Japan Society for the Promotion of Science Core-to-Core Program","award":["JPJ008837"],"award-info":[{"award-number":["JPJ008837"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Drug resistance and toxic side effects are major challenges in the treatment of babesiosis. As such, new drugs are needed to combat the emergence of drug resistance in\n                      <jats:italic>Babesia<\/jats:italic>\n                      parasites and to develop alternative treatment strategies. A combination of naphthoquine (NQ) and artemisinin is an antimalarial therapy in pharmaceutical markets. The present study repurposed NQ as a drug for the treatment of babesiosis by evaluating the anti-\n                      <jats:italic>Babesia<\/jats:italic>\n                      activity of naphthoquine phosphate (NQP) alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An in vitro growth inhibition assay of NQP was tested on\n                      <jats:italic>Babesia gibsoni<\/jats:italic>\n                      cultures using a SYBR Green I-based fluorescence assay. In addition, the in vivo growth inhibitory effect of NQP was evaluated using BALB\/c mice infected with\n                      <jats:italic>Babesia rodhaini<\/jats:italic>\n                      . The parasitemia level and hematocrit values were monitored to determine the therapeutic efficacy of NQP and the clinical improvements in NQP-treated mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The half maximal inhibitory concentration of NQP against\n                      <jats:italic>B. gibsoni<\/jats:italic>\n                      in vitro was 3.3\u2009\u00b1\u20090.5\u00a0\u03bcM. Oral administration of NQP for 5 consecutive days at a dose of 40\u00a0mg\/kg of body weight resulted in significant inhibition of\n                      <jats:italic>B. rodhaini<\/jats:italic>\n                      growth in mice as compared with that of the control group. All NQP-treated mice survived, whereas the mice in the control group died between days 6 and 9 post-infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This is the first study to evaluate the anti-\n                      <jats:italic>Babesia<\/jats:italic>\n                      activity of NQP in vitro and in vivo. Our findings suggest that NQP is a promising drug for treating\n                      <jats:italic>Babesia<\/jats:italic>\n                      infections, and drug repurposing may provide new treatment strategies for babesiosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-021-05127-0","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T19:04:17Z","timestamp":1641495857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo"],"prefix":"10.1186","volume":"15","author":[{"given":"Shengwei","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloiza May","family":"Galon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Abdo","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumduuren","family":"Tuvshintulga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yae","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoaki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuenan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"5127_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/CMR.13.3.451","volume":"13","author":"MJ Homer","year":"2000","unstructured":"Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev. 2000;13:451\u201369.","journal-title":"Clin Microbiol Rev"},{"key":"5127_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.disamonth.2012.03.007","volume":"58","author":"MJ Kavanaugh","year":"2012","unstructured":"Kavanaugh MJ, Decker CF. Babesiosis. Dis Mon. 2012;58:355\u201360.","journal-title":"Dis Mon"},{"key":"5127_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.vetpar.2006.01.048","volume":"138","author":"HJ Vial","year":"2006","unstructured":"Vial HJ, Gorenflot A. Chemotherapy against babesiosis. Vet Parasitol. 2006;138:147\u201360.","journal-title":"Vet Parasitol"},{"key":"5127_CR4","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2174\/092986712799828355","volume":"19","author":"J Mosqueda","year":"2012","unstructured":"Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem. 2012;19:1504\u201318.","journal-title":"Curr Med Chem"},{"key":"5127_CR5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/cid\/cix477","volume":"65","author":"MS Simon","year":"2017","unstructured":"Simon MS, Westblade LF, Dziedziech A, Visone JE, Furman RR, Jenkins SG, et al. Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia. Clin Infect Dis. 2017;65:1222\u20135.","journal-title":"Clin Infect Dis"},{"key":"5127_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.exppara.2017.10.016","volume":"183","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Watanabe N, Idaka N, Yamamori T, Otsuguro K, Uchida N, et al. Intracellular diminazene aceturate content and adenosine incorporation in diminazene aceturate-resistant Babesia gibsoni isolate in vitro. Exp Parasitol. 2017;183:92\u20138.","journal-title":"Exp Parasitol"},{"key":"5127_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1292\/jvms.12-0140","volume":"74","author":"M Sakuma","year":"2012","unstructured":"Sakuma M, Fukuda K, Takayama K, Kobayashi Y, Shimokawa Miyama T, et al. Molecular epidemiological survey of the Babesia gibsoni cytochrome b gene in western Japan. J Vet Med Sci. 2012;74:1341\u20134.","journal-title":"J Vet Med Sci"},{"key":"5127_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20151519","volume":"213","author":"LA Lawres","year":"2016","unstructured":"Lawres LA, Garg A, Kumar V, Bruzual I, Forquer IP, Renard I, et al. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone. J Exp Med. 2016;213:1307\u201318.","journal-title":"J Exp Med"},{"key":"5127_CR9","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.1038\/nmicrobiol.2016.79","volume":"1","author":"JE Lemieux","year":"2016","unstructured":"Lemieux JE, Tran AD, Freimark L, Schaffner SF, Goethert H, Andersen KG, et al. A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse. Nat Microbiol. 2016;1:16079.","journal-title":"Nat Microbiol"},{"key":"5127_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.idc.2015.02.008","volume":"29","author":"EG Vannier","year":"2015","unstructured":"Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ. Babesiosis. Infect Dis Clin North Am. 2015;29:357\u201370.","journal-title":"Infect Dis Clin North Am"},{"key":"5127_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/archinte.158.19.2149","volume":"158","author":"DJ White","year":"1998","unstructured":"White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human babesiosis in New York state: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med. 1998;158:2149\u201354.","journal-title":"Arch Intern Med"},{"key":"5127_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6806a1","volume":"68","author":"EB Gray","year":"2019","unstructured":"Gray EB, Herwaldt BL. Babesiosis surveillance\u2014United States, 2011\u20132015. MMWR Surveill Summ. 2019;68:1\u201311.","journal-title":"MMWR Surveill Summ"},{"key":"5127_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1292\/jvms.20-0382","volume":"82","author":"A Iguchi","year":"2020","unstructured":"Iguchi A, Soma T, Xuan X. Further epidemiological survey for atovaquone resistant related gene of Babesia gibsoni in Japan during 2015\u20132018. J Vet Med Sci. 2020;82:1700\u20133.","journal-title":"J Vet Med Sci"},{"key":"5127_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.vetpar.2011.09.031","volume":"185","author":"A Iguchi","year":"2012","unstructured":"Iguchi A, Matsuu A, Ikadai H, Talukder MH, Hikasa Y. Development of in vitro atovaquone-resistant Babesia gibsoni with a single-nucleotide polymorphism in cytb. Vet Parasitol. 2012;185:145\u201350.","journal-title":"Vet Parasitol"},{"key":"5127_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.actatropica.2003.11.008","volume":"89","author":"J Wang","year":"2004","unstructured":"Wang J, Cao W, Shan C, Zhang M, Li G, Ding D, et al. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 2004;89:375\u201381.","journal-title":"Acta Trop"},{"key":"5127_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40265-016-0572-5","volume":"76","author":"BR Moore","year":"2016","unstructured":"Moore BR, Laman M, Salman S, Batty KT, Page-Sharp M, Hombhanje F, et al. Naphthoquine: an emerging candidate for artemisinin combination therapy. Drugs. 2016;76:789\u2013804.","journal-title":"Drugs"},{"key":"5127_CR17","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/ph3123581","volume":"3","author":"FW Hombhanje","year":"2010","unstructured":"Hombhanje FW, Huang Q. Artemisinin-naphthoquine combination (ARCO\u00ae): an overview of the progress. Pharmaceuticals. 2010;3:3581\u201393.","journal-title":"Pharmaceuticals"},{"key":"5127_CR18","volume":"65","author":"M Liu","year":"2021","unstructured":"Liu M, Ji S, Kondoh D, Galon EM, Li J, Tomihari M, et al. Tafenoquine is a promising drug candidate for the treatment of babesiosis. Antimicrob Agents Chemother. 2021;65: e0020421.","journal-title":"Antimicrob Agents Chemother"},{"key":"5127_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1292\/jvms.64.571","volume":"64","author":"F Sunaga","year":"2002","unstructured":"Sunaga F, Namikawa K, Kanno Y. Continuous in vitro culture of erythrocytic stages of Babesia gibsoni and virulence of the cultivated parasite. J Vet Med Sci. 2002;64:571\u20135.","journal-title":"J Vet Med Sci"},{"key":"5127_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-3024.2008.01026.x","volume":"30","author":"MA Terkawi","year":"2008","unstructured":"Terkawi MA, Zhang G, Jia H, Aboge G, Goo YK, Nishikawa Y, et al. C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection. Parasite Immunol. 2008;30:365\u201370.","journal-title":"Parasite Immunol"},{"key":"5127_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2020.102054","volume":"75","author":"MA Rizk","year":"2020","unstructured":"Rizk MA, Ji S, Liu M, El-Sayed SAE, Li Y, Byamukama B, et al. Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay. Parasitol Int. 2020;75: 102054.","journal-title":"Parasitol Int"},{"key":"5127_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13071-020-04235-7","volume":"13","author":"L Carvalho","year":"2020","unstructured":"Carvalho L, Tuvshintulga B, Nugraha AB, Sivakumar T, Yokoyama N. Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo. Parasit Vectors. 2020;13:362.","journal-title":"Parasit Vectors"},{"key":"5127_CR23","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1128\/AAC.01614-15","volume":"60","author":"B Tuvshintulga","year":"2016","unstructured":"Tuvshintulga B, AbouLaila M, Davaasuren B, Ishiyama A, Sivakumar T, Yokoyama N, et al. Clofazimine inhibits the growth of Babesia and Theileria parasites in vitro and in vivo. Antimicrob Agents Chemother. 2016;60:2739\u201346.","journal-title":"Antimicrob Agents Chemother"},{"key":"5127_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijpara.2013.01.007","volume":"43","author":"SN El-Beshbishi","year":"2013","unstructured":"El-Beshbishi SN, Taman A, El-Malky M, Azab MS, El-Hawary AK, El-Tantawy DA. First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection. Int J Parasitol. 2013;43:521\u201330.","journal-title":"Int J Parasitol"},{"key":"5127_CR25","doi-asserted-by":"publisher","first-page":"e02307","DOI":"10.1128\/AAC.02307-19","volume":"64","author":"Z Bei","year":"2020","unstructured":"Bei Z, Li G, Zhao J, Zhang M, Ji X, Wang J. Evaluation of the combination of azithromycin and naphthoquine in animal malaria models. Antimicrob Agents Chemother. 2020;64:e02307-e2319.","journal-title":"Antimicrob Agents Chemother"},{"key":"5127_CR26","first-page":"196","volume":"27","author":"J Wang","year":"2003","unstructured":"Wang J, Zuo B, Xu Z, Sun G, Zhang M, Wang C, et al. Long-term toxicity of co-naphthoquine in beagle dogs. Bull Acad Mil Med Sci. 2003;27:196\u20138.","journal-title":"Bull Acad Mil Med Sci"},{"key":"5127_CR27","first-page":"483","volume-title":"Artemisinin-based and other antimalarials","author":"F Li","year":"2018","unstructured":"Li F, Zhang Z. Chapter 8 -\u00a0Artemisinin\u2013naphthoquine phosphate combination (ARCO). In: Li G, Li Y, Li Z, Zeng M, editors. Artemisinin-based and other antimalarials. London: Academic Press; 2018. p. 483\u2013569."},{"key":"5127_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/infdis\/jiz119","volume":"220","author":"DG Mordue","year":"2019","unstructured":"Mordue DG, Wormser GP. Could the drug tafenoquine revolutionize treatment of Babesia microti infection? J Infect Dis. 2019;220:442\u20137.","journal-title":"J Infect Dis"},{"key":"5127_CR29","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1369\/jhc.2009.953828","volume":"57","author":"AL Peters","year":"2009","unstructured":"Peters AL, Van Noorden CJ. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009;57:1003\u201311.","journal-title":"J Histochem Cytochem"},{"key":"5127_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00219605","volume":"169","author":"MA Rudzinska","year":"1976","unstructured":"Rudzinska MA, Trager W, Lewengrub SJ, Gubert E. An electron microscopic study of Babesia microti invading erythrocytes. Cell Tissue Res. 1976;169:323\u201334.","journal-title":"Cell Tissue Res"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-05127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-021-05127-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-05127-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T19:09:49Z","timestamp":1641496189000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-021-05127-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5127"],"URL":"https:\/\/doi.org\/10.1186\/s13071-021-05127-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1011892\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"23 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were carried out according to the ethical guidelines approved by the Obihiro University of Agriculture and Veterinary Medicine (permit numbers: animal experiment, 20-128; DNA experiment, 1723-4 and 1724-4; pathogen, 201712-5).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}